|
gptkbp:instanceOf
|
gptkb:Corticosteroid
synthetic glucocorticoid
|
|
gptkbp:approvedBy
|
1987
|
|
gptkbp:ATCCode
|
R01AD09
R03BA07
D07AC13
|
|
gptkbp:bioavailability
|
<1% (nasal)
|
|
gptkbp:brand
|
gptkb:Asmanex
gptkb:Nasonex
Elocon
|
|
gptkbp:CASNumber
|
83919-23-7
|
|
gptkbp:chemicalClass
|
corticosteroid ester
|
|
gptkbp:contraindication
|
hypersensitivity to mometasone
|
|
gptkbp:developedBy
|
gptkb:Schering-Plough
|
|
gptkbp:eliminationHalfLife
|
5.8 hours
|
|
gptkbp:excretion
|
urine
bile
|
|
gptkbp:form
|
gptkb:butter
gptkb:hospital
moisturizer
nasal spray
inhaler
|
|
gptkbp:hasMolecularFormula
|
C27H30Cl2O6
|
|
https://www.w3.org/2000/01/rdf-schema#label
|
mometasone furoate
|
|
gptkbp:KEGGID
|
D08109
|
|
gptkbp:legalStatus
|
prescription only
|
|
gptkbp:MedlinePlusID
|
a601056
|
|
gptkbp:MeSH_ID
|
D019821
|
|
gptkbp:metabolism
|
liver
|
|
gptkbp:pregnancyCategory
|
C (US)
B3 (Australia)
|
|
gptkbp:proteinBinding
|
>99%
|
|
gptkbp:PubChem_CID
|
CHEMBL1200698
441336
DB00764
|
|
gptkbp:routeOfAdministration
|
topical
inhalation
intranasal
|
|
gptkbp:sideEffect
|
headache
cough
sore throat
upper respiratory tract infection
nosebleed
|
|
gptkbp:UNII
|
042Z6M9402
|
|
gptkbp:usedFor
|
gptkb:eczema
asthma
allergic rhinitis
nasal polyps
inflammatory skin disorders
|
|
gptkbp:bfsParent
|
gptkb:Nasonex
gptkb:Atectura
gptkb:Enerzair
|
|
gptkbp:bfsLayer
|
6
|